Zacks Research Issues Negative Outlook for Teleflex Earnings

Teleflex Incorporated (NYSE:TFXFree Report) – Equities research analysts at Zacks Research reduced their FY2024 earnings estimates for shares of Teleflex in a research report issued on Wednesday, January 8th. Zacks Research analyst R. Department now forecasts that the medical technology company will earn $13.95 per share for the year, down from their prior forecast of $13.97. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q1 2025 earnings at $3.51 EPS, Q1 2026 earnings at $4.14 EPS, Q2 2026 earnings at $4.16 EPS and Q3 2026 earnings at $4.13 EPS.

Several other equities research analysts have also issued reports on the stock. Mizuho decreased their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial cut their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Royal Bank of Canada dropped their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Get Our Latest Research Report on Teleflex

Teleflex Price Performance

TFX stock opened at $179.00 on Monday. The company’s 50-day moving average price is $185.27 and its two-hundred day moving average price is $216.16. The firm has a market cap of $8.31 billion, a P/E ratio of 35.59, a P/E/G ratio of 1.84 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex has a 12 month low of $171.69 and a 12 month high of $256.85.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s revenue was up 2.4% on a year-over-year basis. During the same quarter last year, the company earned $3.64 EPS.

Institutional Investors Weigh In On Teleflex

Large investors have recently added to or reduced their stakes in the company. Oak Thistle LLC lifted its holdings in Teleflex by 243.9% during the 4th quarter. Oak Thistle LLC now owns 10,695 shares of the medical technology company’s stock worth $1,903,000 after purchasing an additional 7,585 shares in the last quarter. Mendota Financial Group LLC bought a new position in Teleflex in the 4th quarter valued at $124,000. Bridge Creek Capital Management LLC grew its position in shares of Teleflex by 1.7% during the 4th quarter. Bridge Creek Capital Management LLC now owns 16,730 shares of the medical technology company’s stock valued at $2,978,000 after purchasing an additional 285 shares in the last quarter. Czech National Bank increased its holdings in shares of Teleflex by 4.9% in the fourth quarter. Czech National Bank now owns 10,070 shares of the medical technology company’s stock worth $1,792,000 after purchasing an additional 472 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in Teleflex by 4.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company’s stock valued at $588,000 after buying an additional 128 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.76%. Teleflex’s payout ratio is currently 27.04%.

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Earnings History and Estimates for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.